133 related articles for article (PubMed ID: 9206711)
21. 1-Hydroxypyrene as an indicator of the mutagenicity of coal tar after activation with human liver preparations.
Jongeneelen FJ; vd Akker W; Bos RP; Anzion RB; Theuws JL; Roelofs HM; Henderson PT
Mutat Res; 1988 Feb; 204(2):195-201. PubMed ID: 3278210
[TBL] [Abstract][Full Text] [Related]
22. Dermal exposure and urinary 1-hydroxypyrene among asphalt roofing workers.
McClean MD; Rinehart RD; Sapkota A; Cavallari JM; Herrick RF
J Occup Environ Hyg; 2007; 4 Suppl 1():118-26. PubMed ID: 17503278
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of different bacterial assays in detecting mutagens in urine of humans exposed to polycyclic aromatic hydrocarbons.
Granella M; Clonfero E
Mutat Res; 1992 Jul; 268(1):131-7. PubMed ID: 1378179
[TBL] [Abstract][Full Text] [Related]
24. Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1-hydroxypyrene in urine.
Van Rooij JG; Veeger MM; Bodelier-Bade MM; Scheepers PT; Jongeneelen FJ
Int Arch Occup Environ Health; 1994; 66(1):55-65. PubMed ID: 7927844
[TBL] [Abstract][Full Text] [Related]
25. Urinary levels of 1-hydroxypyrene in children residing near a coal-fired power plant.
Hu SW; Chan YJ; Hsu HT; Wu KY; ChangChien GP; Shie RH; Chan CC
Environ Res; 2011 Nov; 111(8):1185-91. PubMed ID: 21803351
[TBL] [Abstract][Full Text] [Related]
26. Chromosomal alterations in peripheral blood lymphocytes, urinary mutagenicity and excretion of polycyclic aromatic hydrocarbons in six psoriatic patients undergoing coal tar therapy.
Sarto F; Zordan M; Tomanin R; Mazzotti D; Canova A; Cardin EL; Bezze G; Levis AG
Carcinogenesis; 1989 Feb; 10(2):329-34. PubMed ID: 2643486
[TBL] [Abstract][Full Text] [Related]
27. A guidance value of 1-hydroxypyrene in urine in view of acceptable occupational exposure to polycyclic aromatic hydrocarbons.
Jongeneelen FJ
Toxicol Lett; 2014 Dec; 231(2):239-48. PubMed ID: 24831967
[TBL] [Abstract][Full Text] [Related]
28. Nonselective and selective methods for biological monitoring of exposure to coal-tar products.
Bos RP; Jongeneelen FJ
IARC Sci Publ; 1988; (89):389-95. PubMed ID: 3198226
[TBL] [Abstract][Full Text] [Related]
29. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of humans exposed to therapeutical coal tar.
Clonfero E; Zordan M; Cottica D; Venier P; Pozzoli L; Cardin EL; Sarto F; Levis AG
Carcinogenesis; 1986 May; 7(5):819-23. PubMed ID: 3698208
[TBL] [Abstract][Full Text] [Related]
30. Multiple biomarkers study in painters in a shipyard in Korea.
Lee KH; Ichiba M; Zhang J; Tomokuni K; Hong YC; Ha M; Kwon HJ; Koh SB; Choi HR; Lee KH; Park CG; Cho SH; Hirvonen A; Strickland PT; Vermeulen R; Hayes RB; Kang D
Mutat Res; 2003 Sep; 540(1):89-98. PubMed ID: 12972061
[TBL] [Abstract][Full Text] [Related]
31. Detection of polycyclic aromatic hydrocarbon metabolites by high-pressure liquid chromatography after purification on immunoaffinity columns in urine from occupationally exposed workers.
Bentsen-Farmen RK; Botnen IV; Notø H; Jacob J; Ovrebø S
Int Arch Occup Environ Health; 1999 May; 72(3):161-8. PubMed ID: 10392563
[TBL] [Abstract][Full Text] [Related]
32. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema.
Roelofzen JH; Aben KK; Oldenhof UT; Coenraads PJ; Alkemade HA; van de Kerkhof PC; van der Valk PG; Kiemeney LA
J Invest Dermatol; 2010 Apr; 130(4):953-61. PubMed ID: 20016499
[TBL] [Abstract][Full Text] [Related]
33. Biological exposure limit for occupational exposure to coal tar pitch volatiles at cokeovens.
Jongeneelen FJ
Int Arch Occup Environ Health; 1992; 63(8):511-6. PubMed ID: 1587624
[TBL] [Abstract][Full Text] [Related]
34. Coal tar in dermatology.
Roelofzen JH; Aben KK; van der Valk PG; van Houtum JL; van de Kerkhof PC; Kiemeney LA
J Dermatolog Treat; 2007; 18(6):329-34. PubMed ID: 17852640
[TBL] [Abstract][Full Text] [Related]
35. Occupational exposure to polycyclic aromatic hydrocarbons in a graphite-electrode producing plant: biological monitoring of 1-hydroxypyrene and monohydroxylated metabolites of phenanthrene.
Angerer J; Mannschreck C; Gündel J
Int Arch Occup Environ Health; 1997; 69(5):323-31. PubMed ID: 9192216
[TBL] [Abstract][Full Text] [Related]
36. Polycyclic aromatic hydrocarbon exposure in coal liquefaction workers: the value of urinary 1-hydroxypyrene excretion in the development of occupational hygiene control strategies.
Quinlan R; Kowalczyk G; Gardiner K; Calvert IA; Hale K; Walton ST
Ann Occup Hyg; 1995 Jun; 39(3):329-46. PubMed ID: 7793752
[TBL] [Abstract][Full Text] [Related]
37. Covalent binding of components of coal-tar, creosote and bitumen to the DNA of the skin and lungs of mice following topical application.
Schoket B; Hewer A; Grover PL; Phillips DH
Carcinogenesis; 1988 Jul; 9(7):1253-8. PubMed ID: 3383342
[TBL] [Abstract][Full Text] [Related]
38. Genotoxic and apoptotic effects of Goeckerman therapy for psoriasis.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Palicka V; Ranna D; Fiala Z
Int J Dermatol; 2010 Mar; 49(3):289-94. PubMed ID: 20465666
[TBL] [Abstract][Full Text] [Related]
39. The relationship between polycyclic aromatic hydrocarbons in air and in urine of workers in a Söderberg potroom.
Tjoe Ny E; Heederik D; Kromhout H; Jongeneelen F
Am Ind Hyg Assoc J; 1993 Jun; 54(6):277-84. PubMed ID: 8328359
[TBL] [Abstract][Full Text] [Related]
40. Biological monitoring of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabolites in urine.
Clonfero E; Jongeneelen F; Zordan M; Levis AG
IARC Sci Publ; 1990; (104):215-22. PubMed ID: 2228119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
